<unk>  (INN) or<unk>  (former BAN) is a moderate-spectrum β-lactam antibiotic used to treat bacterial infections caused by susceptible microorganisms. It is usually the drug of choice within the class because it is better absorbed, following oral administration, than other beta-lactam antibiotics.<unk>  is susceptible to degradation by β-lactamase-producing bacteria, and so may be given with clavulanic acid to decrease its susceptibility (see below).  It was developed by Beecham in 1972 and is currently marketed by GlaxoSmithKline (the inheritor company) under the original trade name Amoxil.
Amoxicillin detailed information
Erythromycin detailed information
Azithromycin detailed information
Ciprofloxacin detailed information
Community-acquired pneumonia hospital admission decision
Cerivastatin detailed information
Measles other diagnostic studies
Opportunistic infection medical therapy